Sphere 3D Corp. Common Shares short interest in 2024
In 2024, Sphere 3D Corp. Common Shares's disclosed short interest ran from 3.27% of shares outstanding on 15 Mar 2024 to 2.47% on 31 Dec 2024, a change of -0.80 percentage points. The year's high was 6.83% on 28 Jun 2024 and its low 2.00% on 13 Sep 2024, averaging 4.08% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.41 days on 30 Sep 2024. Full history: Sphere 3D Corp. Common Shares.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 3.27% (15 Mar 2024)
- End of year
- 2.47% (31 Dec 2024)
- Change
- -0.80 pp
- High
- 6.83% (28 Jun 2024)
- Low
- 2.00% (13 Sep 2024)
- Average
- 4.08%
- Highest days to cover
- 3.41 (30 Sep 2024)
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Mar 2024 | 3.27% | 1.00 | |
| 28 Mar 2024 | 3.75% | 1.11 | |
| 15 Apr 2024 | 3.91% | 1.95 | |
| 30 Apr 2024 | 4.25% | 2.16 | |
| 15 May 2024 | 4.68% | 2.92 | |
| 31 May 2024 | 5.68% | 1.12 | |
| 14 Jun 2024 | 5.98% | 1.14 | |
| 28 Jun 2024 | 6.83% | 1.54 | |
| 15 Jul 2024 | 6.04% | 1.85 | |
| 31 Jul 2024 | 5.32% | 1.61 | |
| 15 Aug 2024 | 2.87% | 1.90 | |
| 30 Aug 2024 | 3.96% | 2.18 | |
| 13 Sep 2024 | 2.00% | 1.28 | |
| 30 Sep 2024 | 3.96% | 3.41 | |
| 31 Oct 2024 | 2.70% | 1.00 | |
| 15 Nov 2024 | 3.40% | 1.00 | |
| 29 Nov 2024 | 2.82% | 1.00 | |
| 13 Dec 2024 | 3.60% | 1.00 | |
| 31 Dec 2024 | 2.47% | 1.00 |
See also: Sphere 3D Corp. Common Shares's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.